From Fat to Healing: How Adipose‐Derived Stem Cells Are Changing the Game for Diabetic Foot Ulcers—A Perspective
While ADSCs represent a promising therapeutic option for DFUs and provide valuable insights for a wider array of chronic wound therapies, their clinical application requires careful consideration of safety concerns, including risks of tumor formation and immune response issues. Future advancements in cell processing and well-structured clinical trials will be essential to ensuring efficacy across diverse populations in the broader context of regenerative medicine.
Authors
- P. Thirumal (ORCID: https://orcid.org/0000-0002-7817-636X)
- Kumar Rangarajalu (ORCID: https://orcid.org/0000-0002-9848-030X)
- Prithiviraj Nagarajan (ORCID: https://orcid.org/0000-0002-9428-6243)
- Anusheela Howlader (ORCID: https://orcid.org/0000-0001-9494-9775)
- Arun Daniel Jayakumar (ORCID: https://orcid.org/0000-0001-5196-6735)
- Pavithra Muthiah (ORCID: https://orcid.org/0009-0003-3230-608X)
- Mani Rajarathinam (ORCID: https://orcid.org/0009-0002-4187-0128)
- Nisha Perumal (ORCID: https://orcid.org/0009-0000-4521-7332)
Institutions
- Vinayaka Missions University (IN)
- Tamil Nadu Government Multi Super Speciality Hospital (IN)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/hsr2.71385
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00